IP at the Supreme Court Series: Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

Apr 29 | 5:00 - 6:00pm EDT | Hybrid | Reception to follow
Registration Required

Moderated by Professor Charles Duan

American University Washington College of Law regularly invites counsel of record and counsel for selected amici to offer post-argument reflections in intellectual property (and related) cases heard by the Supreme Court. These events are held on the afternoon of oral argument before the Court. 

ISSUE

(1) Whether, when a generic drug label fully carves out a patented use, allegations that the generic drugmaker calls its product a “generic version” and cites public information about the branded drug (e.g., sales) are enough to plead induced infringement of the patented use; and (2) whether a complaint states a claim for induced infringement of a patented method if it does not allege any instruction or other statement by the defendant that encourages, or even mentions, the patented use

PANELISTS - To Be Announced

_{^{ALL BRIEFS AVAILABLE ON SCOTUSblog: Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc.}} 

Link to Oral Argument Transcript

Link to Event Recording

Decision:

Accommodation Request
If you would like to request disability-related accommodation or accessibility information, please contact PIJIP at pijip@wcl.american.edu.   Requests should be made two weeks before the event date.